Chauhan, Shekhar
Srivastava, Shobhit
Kumar, Pradeep
Patel, Ratna
Article History
Received: 9 July 2021
Accepted: 28 February 2022
First Online: 15 March 2022
Declarations
:
: The authors were not involved in data collection process and therefore they did not require any ethical approval or consent to participate. The LASI data is secondary in nature. The data is freely available on request and survey agencies that conducted the field survey for the data collection have collected a prior consent from the respondent. The ethical clearance was provided by Indian Council of Medical Research (ICMR), India. The survey agencies that collected data followed all the protocols. To maximize the cooperation of the sampled HHs and individuals, participants were provided with information brochures explaining the purpose of the survey, ways of protecting their privacy, and the safety of the health assessments as part of the ethics protocols. As per ethics protocols, consent forms were administered to each HH and age-eligible individual. In accordance with Human Subjects Protection, four consent forms were used in the LASI: Household Informed Consent, Individual Informed Consent, Consent for Blood Samples Collection for Storage and Future Use (DBS), and Proxy Consent. For each survey participant, the study protocol was described and the steps of each biomarker test were demonstrated by the trained health investigators. Participant’s informed consent was obtained for the interviews. Since, the survey obtained either signed or oral consent, it was feasible for each participant to provide his/her consent. All methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.